Summit Global Investments’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Summit Global Investments's LMAT Position: Q1 2026 in Review
Summit Global Investments held its LeMaitre Vascular (LMAT) position steady in Q1 2026 at 3,554 shares worth $388K. The position accounts for 0.02% of the portfolio, ranked #376.
Summit Global Investments first reported a position in LMAT in Q2 2017 and has held it in 14 quarters since. The position peaked at $1.1M in Q4 2023. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Summit Global Investments held 3,554 shares of LeMaitre Vascular worth $388K as of Q1 2026.
- Summit Global Investments left its LeMaitre Vascular share count unchanged in Q1 2026.
- LeMaitre Vascular made up 0.02% of Summit Global Investments's portfolio in Q1 2026, its #376 holding.
- Summit Global Investments first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 14 quarters since.
- Summit Global Investments's LeMaitre Vascular position peaked at $1.1M in Q4 2023.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.